Peer Review History
| Original SubmissionApril 26, 2022 |
|---|
|
PONE-D-22-12241Automated Multi-class Classification of Otitis Media using Deep LearningPLOS ONE Dear Dr. Ahn, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. If the authors choose to submit a revised version of the manuscript, please include an itemized and detailed response to the comments made by the Editor and the Reviewers (see below). Please submit your revised manuscript by Aug 05 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Rafael da Costa Monsanto, M.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: "This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIT).(No. 2021R1A2C2010048)" Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. Additional Editor Comments: Please address the comments made by all the reviewers. Although reviewers agree this is an interesting study, there are several concerns that must be addressed before the article is considered for publication. Major concerns included: - Grammar and syntax review is necessary; - A more detailed description of the methods is needed (calculation of sample size, validation of methods, experience of examiners, inter-observer agreement, etc); - The IRB protocol number must be included in the body of the manuscript; - What does the category "None" entitles; - The lack of inclusion / differentiation of acute otitis media and otomycosis. Please include an itemized, detailed response to the comments made by all reviewers. If not yet done so, please make all data available or provide a detailed explanation why some of the data must not be shared. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear authors Thank you for this interesting study. This maybe helpful for general practitioners, pediatricians and other specialities that may work with some patients and will present some challenges for their diagnosis of middle ear diseases. However, the presentation of data in tables and figures look even more complete than theie explanations on the manuscript. Also there are some detailed issues with English writing. This manuscript will be totally benefit of a refinement of syntax and grammar. Some phrases look pretty colloquial for the scope of this journal. There are some other questions regarding the manuscript 1. Why don't you included the acute otitis media? this is one of the most common ear diseases in children and the assessment of this disease will enrich the study. 2. In the study, you only included two researchers, and one otologist that we do not know their time at practice, that would be really helpful to know it. Another question is variability between researchers, did you take it during the study? and also the variability between ears of a same patient, I think, this needs to be addressed. You may need to clarify if both researchers were blinded or not and how was blinding 3. It is a bit tough to know what is first and secondary class, throughout the text, is very confusing for readers 4. The classification 'none', sometimes is confused with OME and COM, this needs to be clear for readers 5. Will be very interesting if the discussion is refined and comparison with other softwares and tools is made Your work is very interesting but needs to be refined in grammar, syntax and some specific details in the methodology and results Reviewer #2: Thank you very much for the opportunity to review this quite fascinating manuscript for PLOS ONE. In this retrospective study, authors aimed to assess the impact of concurrent changes of the tympanic membrane (perforation, myringitis and more) by using deep learning. Despite of this interesting approach, I have few comments. 1. TITLE: I think it should me more appropriate if authors change the title for something more related to classification of tympanic membrane changes by using deep learning assessment. 2. MATERIALS AND METHODS: How the samples were collected? What equipment was used and how images were processed? How distant from the tympanic membrane photos were taken? Was the method reproducible? 3. Please, write the IRB number in the manuscript. 4. Was the method already validated anteriorly? 5. It is interesting that ventilation tubes were not confused with TM perforation. 6. I suggest the authors to write a paragraph discussing the importance of the deep learning in assessing the tympanic membrane also in times of telemedicine. 7. Line 199: "images inyo three classes" (into?) 8. I suggest the authors to re-write the last paragraph in order to add the conclusion section. 9. D the authors found any correlation among size of perforation and better results in automated classification? Reviewer #3: This retrospective study built a database of otoendoscopic images including multiple diseases and investigate the impact of concurrent diseases on the classification performance of deep learning network on the diagnostic performance using algorithm for multi-class classification of otitis media. However, I would like to point out some aspects that need clarification. 1) For the primary classification of the images in the 3 categories, the category "NONE" was not clear which cases would be included, if images without diagnosis of chronic otitis media and otitis media with effusion, or if there would also be images of normal ears, cerumen? In addition, for the secondary classification, there was the allocation of a very small number of certain cases, mainly of otomycoses, which greatly impaired the accuracy of this diagnosis. 2) As the author himself reports in the justifications for this study, there are several criteria for the diagnosis of tympanic membrane lesions and the criteria used by specialists (a skilled otologist) for the diagnosis of myringitis in this study were not described. 3) It needs to be clarified why the construction of this algorithm does not include the diagnosis of acute otitis media and cerumen, which could certainly impact the otoendoscopies performed by other non-ENT professionals who did not clean the external acoustic meatus. 4) Several deep learning models for the diagnosis of middle ear diseases have already been developed and it is not described what are the real differences of the previous models in relation to the combined model of this study and if the images used were still images or otoendoscopic video sequence? 5) It should be further described how this model can reduce inference time and computational resources for diagnostic support. 6) the titles of figures 2, 3 and 4 are in bold and without focus, making it very difficult to read. 7) The conclusion in the abstract is extremely broad, making inferences that cannot be supported with the result presented and we emphasize that what is described at the end of the manuscript is much more faithful to the results presented in the study. 8) We suggest checking the writing of the manuscript because there are typos. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Automated Multi-class Classification for Prediction of Tympanic Membrane Changes with Deep Learning Models PONE-D-22-12241R1 Dear Dr. Ahn, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Rafael da Costa Monsanto, M.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear authors Thank you for addressing all our comments. Now the manuscript looks even clearer and concise. The techniques and the graphics are pretty well explained which highlights the relevance of the methods used. Reviewer #3: Thank you for thoroughly addressing the comments. The authors have provided corresponding information and the manuscript has improved overall. Findings from the additional analysis are interesting and remain relevant. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-22-12241R1 Automated Multi-class Classification for Prediction of Tympanic Membrane Changes with Deep Learning Models Dear Dr. Ahn: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Rafael da Costa Monsanto Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .